Genome-wide analysis of Saccharomyces cerevisiae identifies cellular processes affecting intracellular aggregation of Alzheimer's amyloid-β42: Importance of lipid homeostasis

Molecular Biology of the Cell

Volumn 25, Issue 15, 2014, Pages 2235-2249

  Nair, S ^a   Traini, M ^a   Dawes, I W ^a,b   Perrone, Gabriel G ^c  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b ANZAC Research Institute   (Australia)

^c UNIVERSITY OF WESTERN SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; CHECKPOINT KINASE 2; CYTIDINE DIPHOSPHATE DIGLYCERIDE; GREEN FLUORESCENT PROTEIN; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLETHANOLAMINE; PHOSPHATIDYLETHANOLAMINE METHYLTRANSFERASE; PHOSPHATIDYLSERINE; PHOSPHATIDYLSERINE DECARBOXYLASE; PHOSPHOLIPID; AMYLOID BETA PROTEIN; AMYLOID BETA-PROTEIN (1-42); PEPTIDE FRAGMENT; PROTEIN AGGREGATE; RECOMBINANT PROTEIN; SACCHAROMYCES CEREVISIAE PROTEIN;

ALZHEIMER DISEASE; ARTICLE; CELL AGGREGATION; CELLULAR DISTRIBUTION; CONFOCAL MICROSCOPY; DELETION MUTANT; DISEASE ASSOCIATION; DISEASE COURSE; ENDOPLASMIC RETICULUM; GENE DELETION; GENE IDENTIFICATION; GENE OVEREXPRESSION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC SCREENING; LIPID HOMEOSTASIS; MULTIVESICULAR BODY; NONHUMAN; PHOSPHOLIPID METABOLISM; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SACCHAROMYCES CEREVISIAE; FUNGAL GENOME; GENE INACTIVATION; GENETICS; HUMAN; LIPID METABOLISM; METABOLISM; PROTEINOSIS;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; GENE KNOCKOUT TECHNIQUES; GENOME, FUNGAL; HUMANS; LIPID METABOLISM; METABOLIC NETWORKS AND PATHWAYS; PEPTIDE FRAGMENTS; PROTEIN AGGREGATES; PROTEIN AGGREGATION, PATHOLOGICAL; RECOMBINANT PROTEINS; SACCHAROMYCES CEREVISIAE; SACCHAROMYCES CEREVISIAE PROTEINS;

EID: 84905215665     PISSN: 10591524     EISSN: 19394586     Source Type: Journal    
DOI: 10.1091/mbc.E13-04-0216     Document Type: Article

References (109)

1. Alberti S, Gitler AD, Lindquist S (2007). A suite of Gateway cloning vectors for high-throughput genetic analysis in Saccharomyces cerevisiae. Yeast 24, 913-919. (Pubitemid 47611130)
2. Almeida CG, Takahashi RH, Gouras GK (2006). Beta-amyloid accumulation impairs multivesicular body sorting by inhibiting the ubiquitin-proteasome system. J Neurosci 26, 4277-4288. (Pubitemid 44315387)
3. Ambroziak J, Henry SA (1994). INO2 and INO4 gene products, positive regulators of phospholipid biosynthesis in Saccharomyces cerevisiae, form a complex that binds to the INO1 promoter. J Biol Chem 269, 15344-15349. (Pubitemid 24198387)
4. Atamna H, Frey WH (2007). Mechanisms of mitochondrial dysfunction and energy deficiency in Alzheimer's disease. Mitochondrion 7, 297-310. (Pubitemid 47300175)
5. Aytan N, Choi JK, Carreras I, Kowall NW, Jenkins BG, Dedeoglu A (2013). Combination therapy in a transgenic model of Alzheimer's disease. Exp Neurol 250C, 228-238.
6. Bailis AM, Poole MA, Carman GM, Henry SA (1987). The membrane-associated enzyme phosphatidylserine synthase is regulated at the level of mRNA abundance. Mol Cell Biol 7, 167-176. (Pubitemid 17230396)
7. Bi X-H, Zhao H-L, Zhang Z-X, Zhang J-W (2011). PEMT G523A (V175M) is associated with sporadic Alzheimer's disease in a Chinese population. J Mol Neurosci 46, 505-508.
8. Bubber P, Haroutunian V, Fisch G, Blass JP, Gibson GE (2005). Mitochondrial abnormalities in Alzheimer brain: mechanistic implications. Ann Neurol 57, 695-703. (Pubitemid 40628858)
9. Caine J, Sankovich S, Antony H, Waddington L, Macreadie P, Varghese J, Macreadie I (2007). Alzheimer's Abeta fused to green fluorescent protein induces growth stress and a heat shock response. FEMS Yeast Res 7, 1230-1236. (Pubitemid 47622047)
10. Caspersen C, Wang N, Yao J, Sosunov A, Chen X, Lustbader JW, Xu HW, Stern D, McKhann G, Yan SD (2005). Mitochondrial Abeta: a potential focal point for neuronal metabolic dysfunction in Alzheimer's disease. FASEB J 19, 2040-2041. (Pubitemid 41759758)
11. Chaturvedi RK, Beal MF (2013). Mitochondria targeted therapeutic approaches in Parkinson's and Huntington's diseases. Mol Cell Neurosci 55, 101-114.
12. Chi EY, Ege C, Winans A, Majewski J, Wu G, Kjaer K, Lee KYC (2008). Lipid membrane templates the ordering and induces the fibrillogenesis of Alzheimer's disease amyloid-β peptide. Proteins 72, 1-24. (Pubitemid 351809143)
13. Daum G, Bohni PC, Schatz G (1982). Import of proteins into mitochondria. Cytochrome b2 and cytochrome c peroxidase are located in the intermembrane space of yeast mitochondria. J Biol Chem 257, 13028-13033.
14. D'Angelo F, Vignaud H, Di Martino J, Salin B, Devin A, Cullin C, Marchal C (2013). A yeast model for amyloid-beta aggregation exemplifies the role of membrane trafficking and PICALM in cytotoxicity. Dis Model Mech 6, 206-216.
15. de Leon MJ et al. (1983). Positron emission tomographic studies of aging and Alzheimer disease. Am J Neuroradiol 4, 568-571.
16. Dimmer KS, Fritz S, Fuchs F, Messerschmitt M, Weinbach N, Neupert W, Westermann B (2002). Genetic basis of mitochondrial function and morphology in Saccharomyces cerevisiae. Mol Biol Cell 13, 847-853. (Pubitemid 34250350)
17. Ege C, Lee KY (2004). Insertion of Alzheimer's A beta 40 peptide into lipid monolayers. Biophys J 87, 1732-1740. (Pubitemid 39167029)
18. Ege C, Majewski J, Wu G, Kjaer K, Lee KY (2005). Templating effect of lipid membranes on Alzheimer's amyloid beta peptide. Chemphyschem 6, 226-229. (Pubitemid 40379862)
19. Epstein CB, Waddle JA, Hale WT, Dave V, Thornton J, Macatee TL, Garner HR, Butow RA (2001). Genome-wide responses to mitochondrial dysfunction. Mol Biol Cell 12, 297-308. (Pubitemid 33051576)
20. Flower TR, Chesnokova LS, Froelich CA, Dixon C, Witt SN (2005). Heat shock prevents alpha-synuclein-induced apoptosis in a yeast model of Parkinson's disease. J Mol Biol 351, 1081-1100. (Pubitemid 41133454)
21. Fox TD, Folley LS, Mulero JJ, McMullin TW, Thorsness PE, Hedin LO, Costanzo MC (1991). Analysis and manipulation of yeast mitochondrial genes. Methods Enzymol 194, 149-165.
22. Frisardi V, Panza F, Seripa D, Farooqui T, Farooqui AA (2011). Glycerophospholipids and glycerophospholipid-derived lipid mediators: a complex meshwork in Alzheimer's disease pathology. Prog Lipid Res 50, 313-330.
23. Gavin AC et al. (2002). Functional organization of the yeast proteome by systematic analysis of protein complexes. Nature 415, 141-147.
24. Gellermann GP, Ullrich K, Unger C, Fandrich M, Sauter S, Diekmann S (2007). Identification of molecular compounds critical to Alzheimer's-like plaque formation. J Neurosci Res 85, 2037-2044. (Pubitemid 47051492)
25. Gelperin DM et al. (2005). Biochemical and genetic analysis of the yeast proteome with a movable ORF collection. Genes Dev 19, 2816-2826. (Pubitemid 41739967)
26. Giaever G et al. (2002). Functional profiling of the Saccharomyces cerevisiae genome. Nature 418, 387-391. (Pubitemid 34826834)
27. Gibson GE, Blass JP, Beal MF, Bunik V (2005). The alpha-ketoglutarate- dehydrogenase complex: a mediator between mitochondria and oxidative stress in neurodegeneration. Mol Neurobiol 31, 43-63. (Pubitemid 41271193)
28. Gibson GE, Park LC, Sheu KF, Blass JP, Calingasan NY (2000). The alpha-ketoglutarate dehydrogenase complex in neurodegeneration. Neurochem Int 36, 97-112.
29. Giorgini F, Guidetti P, Nguyen Q, Bennett SC, Muchowski PJ (2005). A genomic screen in yeast implicates kynurenine 3-monooxygenase as a therapeutic target for Huntington disease. Nat Genet 37, 526-531. (Pubitemid 40617282)
30. Glenner GG, Wong CW (1984). Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun 120, 885-890. (Pubitemid 14104991)
31. Gouras GK et al. (2000). Intraneuronal Abeta42 accumulation in human brain. Am J Pathol 156, 15-20. (Pubitemid 30644433)
32. Gouras GK, Almeida CG, Takahashi RH (2005). Intraneuronal Abeta accumulation and origin of plaques in Alzheimer's disease. Neurobiol Aging 26, 1235-1244. (Pubitemid 41338539)
33. Greenberg ML, Reiner B, Henry SA (1982). Regulatory mutations of inositol biosynthesis in yeast: isolation of inositol-excreting mutants. Genetics 100, 19-33. (Pubitemid 12013105)
34. Grimm MO, Grosgen S, Riemenschneider M, Tanila H, Grimm HS, Hartmann T (2011). From brain to food: analysis of phosphatidylcholins, lysophosphatidylcholins and phosphatidylcholin-plasmalogens derivates in Alzheimer's disease human post mortem brains and mice model via mass spectrometry. J Chromatogr 1218, 7713-7722.
35. Haass C, Selkoe DJ (2007). Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide. Nat Rev Mol Cell Biol 8, 101-112. (Pubitemid 46432529)
36. Hamada D, Tsumoto K, Sawara M, Tanaka N, Nakahira K, Shiraki K, Yanagihara I (2008). Effect of an amyloidogenic sequence attached to yellow fluorescent protein. Proteins 72, 811-821. (Pubitemid 352000860)
37. Hane F, Drolle E, Gaikwad R, Faught E, Leonenko Z (2011). Amyloid-β aggregation on model lipid membranes: an atomic force microscopy study. J Alzheimers Dis 26, 485-494.
38. Hardy JA, Higgins GA (1992). Alzheimer's disease: the amyloid cascade hypothesis. Science 256, 184-185.
39. Haris M, Cai K, Singh A, Hariharan H, Reddy R (2011). In vivo mapping of brain myo-inositol. Neuroimage 54, 2079-2085.
40. Hillenmeyer ME et al. (2008). The chemical genomic portrait of yeast: uncovering a phenotype for all genes. Science 320, 362-365. (Pubitemid 351555656)
41. Hirsch JP, Henry SA (1986). Expression of the Saccharomyces cerevisiae inositol-1-phosphate synthase (INO1) gene is regulated by factors that affect phospholipid synthesis. Mol Cell Biol 6, 3320-3328.
42. Homann MJ, Henry SA, Carman GM (1985). Regulation of CDP-diacylglycerol synthase activity in Saccharomyces cerevisiae. J Bacteriol 163, 1265-1266. (Pubitemid 15229504)
43. Howlett DR, Jennings KH, Lee DC, Clark MS, Brown F, Wetzel R, Wood SJ, Camilleri P, Roberts GW (1995). Aggregation state and neurotoxic properties of Alzheimer beta-amyloid peptide. Neurodegeneration 4, 23-32.
44. Hung LW, Ciccotosto GD, Giannakis E, Tew DJ, Perez K, Masters CL, Cappai R, Wade JD, Barnham KJ (2008). Amyloid-beta peptide (Abeta) neurotoxicity is modulated by the rate of peptide aggregation: Abeta dimers and trimers correlate with neurotoxicity. J Neurosci 28, 11950-11958.
45. Jarrett JT, Berger EP, Lansbury PTJr (1993). The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease. Biochemistry 32, 4693-4697. (Pubitemid 23162022)
46. Jarrett JT, Lansbury PTJr (1993). Seeding "one-dimensional crystallization" of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie? Cell 73, 1055-1058. (Pubitemid 23180480)
47. Jelicic B, Traven A, Filic V, Sopta M (2005). Mitochondrial dysfunction enhances Gal4-dependent transcription. FEMS Microbiol Lett 253, 207-213. (Pubitemid 41674517)
48. Jesch SA, Zhao X, Wells MT, Henry SA (2005). Genome-wide analysis reveals inositol, not choline, as the major effector of Ino2p-Ino4p and unfolded protein response target gene expression in yeast. J Biol Chem 280, 9106-9118. (Pubitemid 40409605)
49. Kagiwada S, Hosaka K, Murata M, Nikawa J, Takatsuki A (1998). The Saccharomyces cerevisiae SCS2 gene product, a homolog of a synaptobrevin- associated protein, is an integral membrane protein of the endoplasmic reticulum and is required for inositol metabolism. J Bacteriol 180, 1700-1708. (Pubitemid 28173047)
50. Kagiwada S, Zen R (2003). Role of the yeast VAP homolog, Scs2p, in INO1 expression and phospholipid metabolism. J Biochem 133, 515-522. (Pubitemid 36604698)
51. Kanfer JN, Sorrentino G, Sitar DS (1999). Amyloid beta peptide membrane perturbation is the basis for its biological effects. Neurochem Res 24, 1621-1630.
52. Kennedy EP, Weiss SB (1956). The function of cytidine coenzymes in the biosynthesis of phospholipids. J Biol Chem 222, 193-214.
53. Kim W, Hecht MH (2005). Sequence determinants of enhanced amyloidogenicity of Alzheimer Aβ42 peptide relative to Aβ40. J Biol Chem 280, 35069-35076. (Pubitemid 41504642)
54. Kim W, Hecht MH (2008). Mutations enhance the aggregation propensity of the Alzheimer's Abeta peptide. J Mol Biol 377, 565-574.
55. Ko LW, Sheu KF, Thaler HT, Markesbery WR, Blass JP (2001). Selective loss of KGDHC-enriched neurons in Alzheimer temporal cortex: does mitochondrial variation contribute to selective vulnerability? J Mol Neurosci 17, 361-369. (Pubitemid 34123953)
56. Kodaki T, Yamashita S (1987). Yeast phosphatidylethanolamine methylation pathway. Cloning and characterization of two distinct methyltransferase genes. J Biol Chem 262, 15428-15435.
57. Komano H, Seeger M, Gandy S, Wang GT, Krafft GA, Fuller RS (1998). Involvement of cell surface glycosyl-phosphatidylinositol-linked aspartyl proteases in alpha-secretase-type cleavage and ectodomain solubilization of human Alzheimer beta-amyloid precursor protein in yeast. J Biol Chem 273, 31648-31651. (Pubitemid 29177092)
58. LaFerla FM, Green KN, Oddo S (2007). Intracellular amyloid-beta in Alzheimer's disease. Nat Rev Neurosci 8, 499-509.
59. Langui D, Girardot N, El Hachimi KH, Allinquant B, Blanchard V, Pradier L, Duyckaerts C (2004). Subcellular topography of neuronal Abeta peptide in APPxPS1 transgenic mice. Am J Pathol 165, 1465-1477. (Pubitemid 39435147)
60. Lemkul JA, Bevan DR (2011). Lipid composition influences the release of Alzheimer's amyloid β-peptide from membranes. Protein Sci 20, 1530-1545.
61. Lesne S, Koh MT, Kotilinek L, Kayed R, Glabe CG, Yang A, Gallagher M, Ashe KH (2006). A specific amyloid-beta protein assembly in the brain impairs memory. Nature 440, 352-357.
62. Lesne S, Kotilinek L (2005). Amyloid plaques and amyloid-beta oligomers: an ongoing debate. J Neurosci 25, 9319-9320. (Pubitemid 41464743)
63. Li G, Rauscher S, Baud S, Pomes R (2012). Binding of inositol stereoisomers to model amyloidogenic peptides. J Phys Chem B 116, 1111-1119.
64. Loewen CJ, Roy A, Levine TP (2003). A conserved ER targeting motif in three families of lipid binding proteins and in Opi1p binds VAP. EMBO J 22, 2025-2035. (Pubitemid 36565528)
65. Loewy BS, Henry SA (1984). The INO2 and INO4 loci of Saccharomyces cerevisiae are pleiotropic regulatory genes. Mol Cell Biol 4, 2479-2485. (Pubitemid 15212263)
66. Ma K, Thomason LA, McLaurin J (2012). scyllo-Inositol, preclinical, and clinical data for Alzheimer's disease. Adv Pharmacol 64, 177-212.
67. Macreadie I, Lotfi-Miri M, Mohotti S, Shapira D, Bennett L, Varghese J (2008). Validation of folate in a convenient yeast assay suited for identification of inhibitors of Alzheimer's amyloid-beta aggregation. J Alzheimers Dis 15, 391-396.
68. Maltseva E, Brezesinski G (2004). Adsorption of amyloid beta (1-40) peptide to phosphatidylethanolamine monolayers. Chemphyschem 5, 1185-1190.
69. Maltseva E, Kerth A, Blume A, Mohwald H, Brezesinski G (2005). Adsorption of amyloid beta (1-40) peptide at phospholipid monolayers. Chembiochem 6, 1817-1824. (Pubitemid 41475274)
70. Manczak M, Anekonda TS, Henson E, Park BS, Quinn J, Reddy PH (2006). Mitochondria are a direct site of A beta accumulation in Alzheimer's disease neurons: implications for free radical generation and oxidative damage in disease progression. Hum Mol Genet 15, 1437-1449.
71. Masters CL, Simms G, Weinman NA, Multhaup G, McDonald BL, Beyreuther K (1985). Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc Natl Acad Sci USA 82, 4245-4249. (Pubitemid 15053619)
72. McCammon MT, Epstein CB, Przybyla-Zawislak B, McAlister-Henn L, Butow RA (2003). Global transcription analysis of Krebs tricarboxylic acid cycle mutants reveals an alternating pattern of gene expression and effects on hypoxic and oxidative genes. Mol Biol Cell 14, 958-972. (Pubitemid 36337445)
73. McGraw P, Henry SA (1989). Mutations in the Saccharomyces cerevisiae OPI3 gene: effects on phospholipid methylation, growth and cross-pathway regulation of inositol synthesis. Genetics 122, 317-330.
74. McLaurin J, Franklin T, Chakrabartty A, Fraser PE (1998). Phosphatidylinositol and inositol involvement in Alzheimer amyloid-beta fibril growth and arrest. J Mol Biol 278, 183-194. (Pubitemid 28196159)
75. McLaurin J, Golomb R, Jurewicz A, Antel JP, Fraser PE (2000). Inositol stereoisomers stabilize an oligomeric aggregate of Alzheimer amyloid beta peptide and inhibit abeta-induced toxicity. J Biol Chem 275, 18495-18502. (Pubitemid 30414810)
76. McLaurin J et al. (2006). Cyclohexanehexol inhibitors of Abeta aggregation prevent and reverse Alzheimer phenotype in a mouse model. Nat Med 12, 801-808. (Pubitemid 44050070)
77. Morell M, de Groot NS, Vendrell J, Aviles FX, Ventura S (2011). Linking amyloid protein aggregation and yeast survival. Mol Biosyst 7, 1121-1128.
78. Naiki H, Nakakuki K (1996). First-order kinetic model of Alzheimer's beta-amyloid fibril extension in vitro. Lab Invest 74, 374-383. (Pubitemid 26072080)
79. Nitsch RM, Blusztajn JK, Pittas AG, Slack BE, Growdon JH, Wurtman RJ (1992). Evidence for a membrane defect in Alzheimer disease brain. Proc Natl Acad Sci USA 89, 1671-1675.
80. Oh S, Hong HS, Hwang E, Sim HJ, Lee W, Shin SJ, Mook-Jung I (2005). Amyloid peptide attenuates the proteasome activity in neuronal cells. Mech Ageing Dev 126, 1292-1299. (Pubitemid 41572246)
81. Outeiro TF, Lindquist S (2003). Yeast cells provide insight into alpha-synuclein biology and pathobiology. Science 302, 1772-1775. (Pubitemid 37505742)
82. Park SK, Pegan SD, Mesecar AD, Jungbauer LM, LaDu MJ, Liebman SW (2011). Development and validation of a yeast high-throughput screen for inhibitors of Abeta(4)(2) oligomerization. Dis Model Mech 4, 822-831.
83. Rosenberger S, Connerth M, Zellnig G, Daum G (2009). Phosphatidylethanolamine synthesized by three different pathways is supplied to peroxisomes of the yeast Saccharomyces cerevisiae. Biochim Biophys Acta 1791, 379-387.
84. Seilheimer B, Bohrmann B, Bondolfi L, Muller F, Stuber D, Dobeli H (1997). The toxicity of the Alzheimer's beta-amyloid peptide correlates with a distinct fiber morphology. J Struct Biol 119, 59-71. (Pubitemid 27294721)
85. Selkoe DJ (1991). Amyloid protein and Alzheimer's disease. Sci Am 265, 68-71, 74-66, 78.
86. Selley ML (2007). A metabolic link between S-adenosylhomocysteine and polyunsaturated fatty acid metabolism in Alzheimer's disease. Neurobiol Aging 28, 1834-1839.
87. Shi Q, Xu H, Yu H, Zhang N, Ye Y, Estevez AG, Deng H, Gibson GE (2011). Inactivation and reactivation of the mitochondrial alpha-ketoglutarate dehydrogenase complex. J Biol Chem 286, 17640-17648.
88. Shimohama S, Tanino H, Sumida Y, Tsuda J, Fujimoto S (1998). Alteration of myo-inositol monophosphatase in Alzheimer's disease brains. Neurosci Lett 245, 159-162. (Pubitemid 28287347)
89. Silva DF, Esteves AR, Oliveira CR, Cardoso SM (2011). Mitochondria: the common upstream driver of amyloid-beta and tau pathology in Alzheimer's disease. Curr Alzheimer Res 8, 563-572.
90. Simmons LK et al. (1994). Secondary structure of amyloid beta peptide correlates with neurotoxic activity in vitro. Mol Pharmacol 45, 373-379. (Pubitemid 24094924)
91. Summers EF, Letts VA, McGraw P, Henry SA (1988). Saccharomyces cerevisiae cho2 mutants are deficient in phospholipid methylation and cross-pathway regulation of inositol synthesis. Genetics 120, 909-922.
92. Tajima Y et al. (2013). Lipidomic analysis of brain tissues and plasma in a mouse model expressing mutated human amyloid precursor protein/tau for Alzheimer's disease. Lipids Health Dis 12, 68.
93. Takahashi RH, Milner TA, Li F, Nam EE, Edgar MA, Yamaguchi H, Beal MF, Xu H, Greengard P, Gouras GK (2002). Intraneuronal Alzheimer abeta42 accumulates in multivesicular bodies and is associated with synaptic pathology. Am J Pathol 161, 1869-1879. (Pubitemid 35265544)
94. Terzi E, Holzemann G, Seelig J (1997). Interaction of Alzheimer beta-amyloid peptide(1-40) with lipid membranes. Biochemistry 36, 14845-14852. (Pubitemid 27524407)
95. Traven A, Wong JM, Xu D, Sopta M, Ingles CJ (2001). Interorganellar communication. Altered nuclear gene expression profiles in a yeast mitochondrial DNA mutant. J Biol Chem 276, 4020-4027.
96. Treusch S et al. (2011). Functional links between Abeta toxicity, endocytic trafficking, and Alzheimer's disease risk factors in yeast. Science 334, 1241-1245.
97. Tzagoloff A, Dieckmann CL (1990). PET genes of Saccharomyces cerevisiae. Microbiol Rev 54, 211-225.
98. Vandebroek T, Terwel D, Vanhelmont T, Gysemans M, Van Haesendonck C, Engelborghs Y, Winderickx J, Van Leuven F (2006). Microtubule binding and clustering of human Tau-4R and Tau-P301L proteins isolated from yeast deficient in orthologues of glycogen synthase kinase-3beta or cdk5. J Biol Chem 281, 25388-25397. (Pubitemid 44401927)
99. Vandebroek T, Vanhelmont T, Terwel D, Borghgraef P, Lemaire K, Snauwaert J, Wera S, Van Leuven F, Winderickx J (2005). Identification and isolation of a hyperphosphorylated, conformationally changed intermediate of human protein tau expressed in yeast. Biochemistry 44, 11466-11475. (Pubitemid 41209082)
100. Vanhelmont T, Vandebroek T, De Vos A, Terwel D, Lemaire K, Anandhakumar J, Franssens V, Swinnen E, Van Leuven F, Winderickx J (2010). Serine-409 phosphorylation and oxidative damage define aggregation of human protein tau in yeast. FEMS Yeast Res 10, 992-1005.
101. Villar-Pique A, Ventura S (2013). Protein aggregation propensity is a crucial determinant of intracellular inclusion formation and quality control degradation. Biochim Biophys Acta 1833, 2714-2724.
102. Waldo GS, Standish BM, Berendzen J, Terwilliger TC (1999). Rapid protein-folding assay using green fluorescent protein. Nat Biotechnol 17, 691-695. (Pubitemid 29316148)
103. Willingham S, Outeiro TF, DeVit MJ, Lindquist SL, Muchowski PJ (2003). Yeast genes that enhance the toxicity of a mutant huntingtin fragment or alpha-synuclein. Science 302, 1769-1772. (Pubitemid 37505741)
104. Winderickx J, Delay C, De Vos A, Klinger H, Pellens K, Vanhelmont T, Van Leuven F, Zabrocki P (2008). Protein folding diseases and neurodegeneration: lessons learned from yeast. Biochim Biophys Acta 1783, 1381-1395.
105. Winzeler EA et al. (1999). Functional characterization of the S. cerevisiae genome by gene deletion and parallel analysis. Science 285, 901-906. (Pubitemid 29381993)
106. Wurth C, Guimard NK, Hecht MH (2002). Mutations that reduce aggregation of the Alzheimer's Abeta42 peptide: an unbiased search for the sequence determinants of Abeta amyloidogenesis. J Mol Biol 319, 1279-1290. (Pubitemid 34729435)
107. Younkin SG (1998). The role of Abeta 42 in Alzheimer's disease. J Physiol 92, 289-292.
108. Zhang W, Espinoza D, Hines V, Innis M, Mehta P, Miller DL (1997). Characterization of beta-amyloid peptide precursor processing by the yeast Yap3 and Mkc7 proteases. Biochim Biophys Acta 1359, 110-122. (Pubitemid 27507813)
109. Zhang H, Komano H, Fuller RS, Gandy SE, Frail DE (1994). Proteolytic processing and secretion of human beta-amyloid precursor protein in yeast. Evidence for a yeast secretase activity. J Biol Chem 269, 27799-27802.